Cargando…

Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine

4-aminopyridine (4AP) is a potassium (K(+)) channel blocker used clinically to improve walking in people with multiple sclerosis (MS). 4AP binds to exposed K(+) channels in demyelinated axons, reducing the leakage of intracellular K(+) and enhancing impulse conduction. Multiple derivatives of 4AP ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yang, Rodríguez-Rangel, Sofia, Zhang, Lauren L., Sánchez-Rodríguez, Jorge E., Brugarolas, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441322/ https://www.ncbi.nlm.nih.gov/pubmed/37609160 http://dx.doi.org/10.1101/2023.08.08.550404

Ejemplares similares

Structure-activity relationship studies of four novel 4-aminopyridine K(+) channel blockers
por: Rodríguez-Rangel, Sofia, et al.
Publicado: (2020)

6-Methylpyridin-3-amine
por: Zhu, Kai, et al.
Publicado: (2008)

6-Methylpyridin-2-amine
por: Draguta, Sergiu, et al.
Publicado: (2012)

3,5-Dichloro-6-methylpyridin-2-amine
por: Fun, Hoong-Kun, et al.
Publicado: (2008)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

N-(4-Chlorophenyl)-4-methylpyridin-2-amine
por: Fairuz, Zainal A., et al.
Publicado: (2010)

Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
por: Joshi, Shreena, et al.
Publicado: (2006)

Conformational exchange in the potassium channel blocker ShK
por: Iwakawa, Naoto, et al.
Publicado: (2019)

Potassium Channels Blockers from the Venom of Androctonus mauretanicus mauretanicus
por: Martin-Eauclaire, Marie-France, et al.
Publicado: (2012)

Chlorido(4-methylpyridin-2-amine-κN (1))(2-{[(4-methylpyridin-2-yl)imino-κN]methyl}phenolato-κO)copper(II)
por: Bhagyaraju, Bussa, et al.
Publicado: (2012)

6-[4-Chloro-2-(trifluoromethyl)phenyl]-3-fluoro-2-methylpyridine
por: Sreenivasa, S., et al.
Publicado: (2012)

Development of a PET radioligand for potassium channels to image CNS demyelination
por: Brugarolas, Pedro, et al.
Publicado: (2018)

Potassium channel blockers restore axonal conduction in CNS trauma and diseases
por: Page, Jessica C., et al.
Publicado: (2016)

Modeling of the Binding of Peptide Blockers to Voltage-Gated Potassium Channels: Approaches and Evidence
por: Novoseletsky, V. N., et al.
Publicado: (2016)

1,3-Bis(6-methylpyridin-2-yl)-1H-imidazol-3-ium hexafluorophosphate
por: Bae, Hoyeon, et al.
Publicado: (2013)

The Inhibitory Effects of Ca(2+) Channel Blocker Nifedipine on Rat Kv2.1 Potassium Channels
por: Li, Xian-Tao, et al.
Publicado: (2015)

Inhibitory effects of potassium channel blockers on carbachol-induced contraction in rat detrusor muscle.
por: Oh, Seung-June, et al.
Publicado: (2003)

Crystal structure of N,N′-bis(diisopropylphosphanyl)-4-methylpyridine-2,6-diamine
por: Stöger, Berthold, et al.
Publicado: (2014)

Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
por: Masaoka, Tatsuhiro, et al.
Publicado: (2018)

Fatty Acid and Related Potassium Kv2 Channel Blockers: Toxicity and Physiological Actions on Mosquitoes
por: Démares, Fabien, et al.
Publicado: (2018)

2-Methylpyridine–urea (1/1)
por: Ashurov, Jamshid, et al.
Publicado: (2012)

Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors
por: Bugay, Vladislav, et al.
Publicado: (2020)

Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers()
por: Heijman, Jordi, et al.
Publicado: (2021)

The Potassium Channel Blocker β-Bungarotoxin from the Krait Bungarus multicinctus Venom Manifests Antiprotozoal Activity
por: Osipov, Alexey V., et al.
Publicado: (2023)

Auxiliary subunits control biophysical properties and response to compound NS5806 of the Kv4 potassium channel complex
por: Zhang, Hongxue, et al.
Publicado: (2019)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

The molecular structure of 4-methylpyridine-N-oxide: Gas-phase electron diffraction and quantum chemical calculations
por: Belova, Natalya V., et al.
Publicado: (2018)

catena-Poly[sodium [[tris(3-methylpyridine-2-carboxylato)europate(III)]-μ-3-methylpyridine-2-carboxylato] trihydrate]
por: Kang, Sung Kwon
Publicado: (2010)

Chemical properties of the divalent cation binding site on potassium channels
Publicado: (1992)

2-Ferrocenyl-6-methylpyridin-3-ol
por: Wang, Zhi-Qiang, et al.
Publicado: (2008)

6-Methylpyridine-2(1H)-thione
por: Lian, Guo-Jun, et al.
Publicado: (2010)

5-Bromo-2-methylpyridine N-oxide
por: Liu, Bo-Nian, et al.
Publicado: (2008)

Flow Synthesis of 2-Methylpyridines via α-Methylation
por: Manansala, Camille, et al.
Publicado: (2015)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore
por: Streit, Anne K., et al.
Publicado: (2011)

Artificial pore blocker acts specifically on voltage-gated potassium channel isoform K(V)1.6
por: Gigolaev, Andrei M., et al.
Publicado: (2022)

Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022)

Chitosan Functionalized with 2-Methylpyridine Cross-Linker Cellulose to Adsorb Pb(II) from Water
por: Lozano-Montante, Jorge, et al.
Publicado: (2021)

When Is a Potassium Channel Not a Potassium Channel?
por: Accili, Eric
Publicado: (2022)

(Tris{2-[2-(2,3,5,6-tetrafluoro-4-iodophenoxy)ethoxy]ethyl}amine)potassium iodide
por: Cavallo, Gabriella, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i5b8jajl7gq3h75aklskrop7pn